DLBCL population:

Patients with hospitalisation for CAR T-cell administration from 2017 to 2020 AND

Diagnosed with DLBCL (International Classification of Diseases \[ICD-10 C833\]) when receiving CAR-T AND

Being 18 years of age or older.

ALL population:

Patients with hospitalisation for CAR T-cell administration from 2017 to 2020 AND

Diagnosed with ALL (ICD-10 C910) when receiving CAR-T AND

Being 25 years of age or younger.

Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data